Customers & Projects
- APEIRON Biologics AG (Vienna, Austria) - Business Development and Alliance Management role
- AprilBio (Seoul, Korea) - Business Development advisor / Licensing
- Autodisplay Biotech GmbH (Düsseldorf, Germany) - Elaboration of a commercialisation strategy for an innovative cell surface display technology
- Avernus Pharma (Dubai, UAE) - Identification of generic product dossiers for MENA
- Biametrics GmbH (Tübingen, Germany) - Business Development for a new biosensor technology in diagnostics & analytics
- bitop AG (Witten, Germany) - Distribution contracts for medical devices in Allergy
- Brandenburg Antiinfektiva GmbH (Borstel, Germany) - CEO / Corporate funding and Partnering of an innovative anti-sepsis drug
- CaBiDi Drug Delivery (Hannover, Germany) - Strategy & Business Development Consulting
- Clarus Therapeutics - Out-licensing of a FDA-approved urology drug to the European market
- D2 Bio Solutions Sdn. Bhd. (Kuala Lumpur, Malaysia) - Sales of OTC products in the German market
- DR. KADE Pharma GmbH (Berlin, Germany) - In-licensing of Rx and OTC products for Germany
- EVER Neuro Pharma GmbH (Unterach, Austria) - In-licensing of late-stage CNS products
- Golden Biotechnology Corp. (Taipeh, Taiwan) - Business Development Advisor
- Hikma Pharma GmbH (Gräfelfing, Germany) - In-licensing of late-stage oncology and urology products
- Intana Bioscience GmbH (Planegg, Germany) - Acquisition of Fee-for-Service deals in Drug Discovery
- Intelligent Pharma (Barcelona, Spain) - Partnering of Computation-aided Drug Discovery solutions
- Laboratorio Eczane (Buenos Aires, Argentina) - In-licensing of products for LATAM markets
- LETI Pharma GmbH - In-licensing of Rx and OTC products for Germany and Spain
- Medicyte GmbH (Heidelberg, Germany) - Sales of primary Hepatocyte cell products
- microDimensions GmbH (Munich, Germany) - Sales of software and services for digital pathology applications
- Mitotech SA (Luxembourg) - Out-licensing of a Phase 3 ophtalmology asset
- Mundipharma GmbH (Limburg, Germany) - Partnerships for late-stage products in oncology, respiratory, and pain
- myPOLS Biotec GmbH (Konstanz, Germany) - Business Development consulting in the field of DNA polymerases
- Novosanis NV (Antwerp, Belgium) - Partnering of an intradermal injection technology
- Orphanix GmbH (Ried im Innkreis, Austria) - Mentor / Strategy for drug development and partnering in orphan diseases
- Polpharma SA (Warsaw, Poland) - In-licensing & Project Management in the field of Biosimilars & Biobetters
- Prestige BioPharma (Singapore) - Global partnering of a late-stage Trastuzumab biosimilar
- PYCAB (Oberschleißheim, Germany) - Start-up consulting (Human polyclonal therapeutic antibodies from transgenic animals)
- Protectimmun GmbH (Gelsenkirchen, Germany) - Strategic partnering of a prophylactic allergy vaccine for newborns
- RIEMSER Pharma GmbH (Berlin, Germany) - In-licensing of products in oncology & neurology for EU markets
- Sandoz Biopharmaceuticals AG (Holzkirchen, Germany) - Interim Management for Business Development in the field of Biosimilars
- Skin Care Pharma GmbH (Petershagen, Germany) - Distribution agreements for dermatology generic
- SiegResearchPharma GmbH (Siegen, Germany) - Placement of clinical development collaborations
- Telormedix SA (Bioggio, Switzerland) - Business development for TLR7-binders in the field of vaccines and anti-inflammation
- Tolmar Ltd. (Dublin, Ireland) - Support with various specialty out-licensing projects
- VERAXA Biotech AG (Heidelberg, Germany) - Implementation of a Business Development process for licensing an antibody generation technology
